Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 16.95
-0.15 (-0.88%)
May 8, 2026, 1:23 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.02 billion as of May 8, 2026. Its market cap has increased by 20.78% in one year.
Market Cap
3.02B
Enterprise Value
4.00B
Revenue
107.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.95
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.02B, a decrease of -24.49%. That is a compound annual growth rate of -2.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.02B | 4.28% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| Shine-On BioMedical | 3.18B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.03B |
| BRIM Biotechnology | 2.98B |
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| HeXun Biosciences | 2.85B |